Comparison of Creatinine and Specific Gravity for Hydration Corrections on Measurement of the Tobacco-Specific Nitrosamine 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in Urine

被引:17
|
作者
Xia, Yang [1 ]
Wong, Lee-Yang [1 ]
Bunker, Brandon C. [2 ]
Bernert, John T. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA
[2] Univ Louisville, Sch Med, Abell Adm Ctr, Louisville, KY 40292 USA
关键词
tobacco-specific nitrosamine; 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL); creatinine; specific gravity; DIETARY-SUPPLEMENT USE; NATIONAL-HEALTH; US POPULATION; SECONDHAND SMOKE; EXPOSURE; VALUES; LUNG; NORMALIZATION; CARCINOGEN; ADJUSTMENT;
D O I
10.1002/jcla.21693
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) was measured in all participants aged 6 years and older from the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey 2007-2008. The suitability of using creatinine or specific gravity for urinary NNAL correction in exposure assessment is examined in this study. Methods: Effects of both specific gravity and creatinine correction on urinary NNAL among smokers were investigated with multiple linear regression models using either normalization or the fitting of creatinine and specific gravity in the model as covariates. Results: When log-scaled NNAL was normalized by either creatinine or specific gravity, R-2 was slightly higher for creatinine than for specific gravity (R-2 = 0.1694 and 0.1439, for creatinine and specific gravity, respectively). When log-scaled NNAL was normalized by both factors, the R-2 was improved (R-2 = 0.2068). When specific gravity or creatinine was included as a covariate separately in the models, they were highly significant factors (P < 0.001, R-2 = 0.2226 and 0.1681 for creatinine and specific gravity, respectively). However, when both were included in the model as covariates, creatinine remained highly significant (P < 0.001), whereas the significance of specific gravity was eliminated (P = 0.4294). Conclusion: This study confirms significant relationships between NNAL concentrations and both urine creatinine and specific gravity. We conclude that creatinine is the more influential and preferred variable to account for urine dilution in tobacco-specific nitrosamine exposure assessment. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:353 / 363
页数:11
相关论文
共 50 条
  • [1] Quantitation of the Tobacco-Specific Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in Urine by LC Tandem Mass Spectrometry
    Xia, Y.
    Bemert, J. T.
    EPIDEMIOLOGY, 2008, 19 (06) : S230 - S230
  • [2] Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
    Ter-Minassian, Monica
    Asomaning, Kofi
    Zhao, Yang
    Chen, Feng
    Su, Li
    Carmella, Steven G.
    Lin, Xihong
    Hecht, Stephen S.
    Christiani, David C.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (06) : 1338 - 1346
  • [3] Stability of the Tobacco-Specific Nitrosamine 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in Urine Samples Stored at Various Temperatures
    Xia, Yang
    Bernert, John T.
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2010, 34 (07) : 411 - 415
  • [4] Comparison of Urine Cotinine and the Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) and Their Ratio to Discriminate Active From Passive Smoking
    Goniewicz, Maciej Lukasz
    Eisner, Mark D.
    Lazcano-Ponce, Eduardo
    Zielinska-Danch, Wioleta
    Koszowski, Bartosz
    Sobczak, Andrzej
    Havel, Christopher
    Jacob, Peyton
    Benowitz, Neal L.
    NICOTINE & TOBACCO RESEARCH, 2011, 13 (03) : 202 - 208
  • [5] Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the united states: NHANES 2007-2008
    Xia, Yang
    Bernert, John T.
    Jain, Ram B.
    Ashley, David L.
    Pirkle, James L.
    BIOMARKERS, 2011, 16 (02) : 112 - 119
  • [6] Improved method for the measurement of tobacco-specific carcinogen biomarker urinary 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in tobacco users
    Brown, Justin
    Xia, Baoyun
    Lee, John
    Blount, Benjamin
    Wang, Lanqing
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [7] Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
    Zimmerman, CL
    Wu, Z
    Upadhyaya, P
    Hecht, SS
    CARCINOGENESIS, 2004, 25 (07) : 1237 - 1242
  • [8] ISOLATION, IDENTIFICATION, AND BIOASSAY OF THE TOBACCO-SPECIFIC N-NITROSAMINE, 4-(METHYLNITROSAMINO)-4-(3-PYRIDYL)-1-BUTANOL
    BRUNNEMANN, KD
    RIVENSON, A
    CZECH, A
    LAVOIE, EJ
    HOFFMANN, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 84 - 84
  • [9] IDENTIFICATION AND ANALYSIS OF A NEW TOBACCO-SPECIFIC N-NITROSAMINE, 4-(METHYLNITROSAMINO)-4-(3-PYRIDYL)-1-BUTANOL
    BRUNNEMANN, KD
    GENOBLE, L
    HOFFMANN, D
    CARCINOGENESIS, 1987, 8 (03) : 465 - 469
  • [10] METABOLITES OF THE TOBACCO-SPECIFIC NITROSAMINE 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IN SMOKERS URINE
    CARMELLA, SG
    AKERKAR, S
    HECHT, SS
    CANCER RESEARCH, 1993, 53 (04) : 721 - 724